CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
effective for the treatment of atopic dermatitis (AD), also known as eczema, or atopic eczema. People with this condition may have ...
Phase 2
Los Angeles, California, United States and 32 other locations
in adults and adolescents with moderate to severe atopic dermatitis (eczema). Eczema (also called atopic dermatitis) is a common sk...
Phase 3
Northridge, California, United States of America and 2 other locations
in adults and adolescents with moderate to severe atopic dermatitis (eczema). Eczema is a condition which can cause dryness, itchin...
Phase 3
Northridge, California, United States of America and 21 other locations
The purpose of this study is to evaluate the safety and efficacy of long-term treatment with IMG-007 in participants with moderate-to-severe atopic d...
Phase 2
Los Angeles, California, United States and 22 other locations
The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.
Phase 2
Los Angeles, California, United States and 39 other locations
participants (in Part A) and participants with atopic dermatitis (eczema) (in Part B). REGN20423 is a study medicine that is only used in cl...
Phase 1
West Hills, California, United States and 6 other locations
This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.
Phase 2
Los Angeles, California, United States and 84 other locations
This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atop...
Phase 2
Los Angeles, California, United States and 27 other locations
The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema ...
Phase 4
Los Angeles, California, United States of America and 71 other locations
The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to \<18...
Phase 3
Los Angeles, California, United States of America and 88 other locations
Clinical trials
Research sites
Resources
Legal